These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 16335697)

  • 1. [Molecular pathogenesis of haemophilia A].
    Habart D
    Cas Lek Cesk; 2005; 144(11):727-32. PubMed ID: 16335697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemophilia A: mutation type determines risk of inhibitor formation.
    Schwaab R; Brackmann HH; Meyer C; Seehafer J; Kirchgesser M; Haack A; Olek K; Tuddenham EG; Oldenburg J
    Thromb Haemost; 1995 Dec; 74(6):1402-6. PubMed ID: 8772209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
    Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
    Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.
    Boekhorst J; Lari GR; D'Oiron R; Costa JM; Nováková IR; Ala FA; Lavergne JM; VAN Heerde WL
    Haemophilia; 2008 Jul; 14(4):729-35. PubMed ID: 18503540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic risk factors for inhibitors to factors VIII and IX.
    Oldenburg J; Pavlova A
    Haemophilia; 2006 Dec; 12 Suppl 6():15-22. PubMed ID: 17123389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics in haemophilia A.
    Oldenburg J; Brackmann HH; Hanfland P; Schwaab R
    Vox Sang; 2000; 78 Suppl 2():33-8. PubMed ID: 10938924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild/moderate haemophilia A: new insights into molecular mechanisms and inhibitor development.
    d'Oiron R; Pipe SW; Jacquemin M
    Haemophilia; 2008 Jul; 14 Suppl 3():138-46. PubMed ID: 18510534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven novel and four recurrent point mutations in the factor VIII (F8C) gene.
    Bogdanova N; Lemcke B; Markoff A; Pollmann H; Dworniczak B; Eigel A; Horst J
    Hum Mutat; 2001 Dec; 18(6):546. PubMed ID: 11748850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of DHPLC analysis for mutation detection in haemophilia A].
    Habart D; Kleibl Z; Hrachovinová I
    Cas Lek Cesk; 2006; 145(6):484-7. PubMed ID: 16836003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population.
    Boekhorst J; Verbruggen B; Lavergne JM; Costa JM; Schoormans SC; Brons PP; van Kraaij MG; Nováková IR; van Heerde WL
    Br J Haematol; 2005 Oct; 131(1):109-17. PubMed ID: 16173970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors in haemophilia: pathophysiology.
    Saint-Remy JM; Lacroix-Desmazes S; Oldenburg J
    Haemophilia; 2004 Oct; 10 Suppl 4():146-51. PubMed ID: 15479388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and function.
    Markoff A; Gerke V; Bogdanova N
    Haemophilia; 2009 Jul; 15(4):932-41. PubMed ID: 19473423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-factor VIII antibodies: a 2005 update.
    Lavigne-Lissalde G; Schved JF; Granier C; Villard S
    Thromb Haemost; 2005 Oct; 94(4):760-9. PubMed ID: 16270627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven novel and four recurrent point mutations in the factor VIII (F8C) gene.
    Bogdanova N; Lemcke B; Markoff A; Pollmann H; Dworniczak B; Eigel A; Horst J
    Hum Mutat; 2002 Jan; 19(1):84. PubMed ID: 11754115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The need for previously untreated patient population studies in understanding the development of factor VIII inhibitors.
    Gomperts ED
    Haemophilia; 2006 Nov; 12(6):573-8. PubMed ID: 17083506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.
    Bi L; Lawler AM; Antonarakis SE; High KA; Gearhart JD; Kazazian HH
    Nat Genet; 1995 May; 10(1):119-21. PubMed ID: 7647782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent occurrence of the novel Arg2163 to His mutation in the factor VIII gene in three unrelated families with haemophila A with different phenotypes. Mutations in brief no. 126. Online.
    Theophilus BD; Enayat MS; Higuchi M; Kazazian HH; Antonarakis SE; Hill FG
    Hum Mutat; 1998; 11(4):334. PubMed ID: 10215414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of mutations in Albanian patients with haemophilia A: identification of ten novel mutations in the factor VIII gene.
    Castaman G; Giacomelli SH; Ghiotto R; Boseggia C; Pojani K; Bulo A; Madeo D; Rodeghiero F
    Haemophilia; 2007 May; 13(3):311-6. PubMed ID: 17498081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of factor VIII mutations in Arab patients with severe haemophilia A.
    Abu-Amero KK; Hellani A; Al-Mahed M; Al-Sheikh I
    Haemophilia; 2008 May; 14(3):484-8. PubMed ID: 18371166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.